Clinical Trial Update: NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NMDA modulation in antidepressant nonresponders with major depressive disorder is currently recruiting. The study is sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: China Medical University Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING